Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€9.52
27.05.21
€32.00
27.05.22
-55.61%
28.05.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Very Future proof/growth oriented business model
buy
Antibe Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.48
08.07.21
-
08.07.22
-80.56%
21.05.22

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€5.70
18.04.22
-
18.04.23
-3.95%
30.04.22

Could be very worthwhile Investment >20% year
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€4.96
07.03.22
-
07.03.23
27.52%
28.03.22

Could be worthwhile Investment >10% per year
Aphria Inc.

Start price
Target price
Perf. (%)
€12.71
20.02.22
€13.00
20.02.23
-
17.03.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.94
12.07.21
-
12.07.22
5.94%
13.03.22

buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€13.28
12.03.21
€24.00
12.03.22
-62.26%
12.03.22

Could be very worthwhile Investment >20% year
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€6.85
20.02.22
-
20.02.23
-14.37%
05.03.22

Could be very worthwhile Investment >20% year
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€16.47
19.03.21
€13.00
19.03.22
-22.87%
20.02.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€17.02
16.02.22
-
16.02.23
-10.26%
19.02.22

Could be worthwhile Investment >10% per year
Canopy Growth Corp

Start price
Target price
Perf. (%)
€7.83
09.02.22
-
09.02.23
-12.11%
18.02.22

Probably not worthwhile Investment
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€36.00
07.02.21
-
07.02.22
-80.67%
08.02.22

Probably not worthwhile Investment
High risks for its business
Few uniques
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.52
23.01.22
-
23.01.23
7.06%
06.02.22

Could be worthwhile Investment >10% per year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.30
23.01.22
-
23.01.23
15.82%
06.02.22

Risky Investment
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€6.43
23.01.22
-
23.01.23
7.21%
06.02.22

Could be very worthwhile Investment >20% year
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€16.62
14.01.22
-
14.01.23
-12.67%
22.01.22

Could be worthwhile Investment >10% per year
buy
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.20
18.09.21
€40.00
31.12.23
61.97%
16.12.21

Could be very worthwhile Investment >20% year
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€3.22
11.06.21
€4.00
11.06.22
-69.57%
14.12.21

Could be worthwhile Investment >10% per year
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.95
10.10.21
€8.00
31.12.23
58.11%
13.12.21

Could be very worthwhile Investment >20% year
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.62
02.12.21
-
02.12.22
45.82%
12.12.21

Risky Investment
buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.22
29.11.21
-
29.11.22
-16.11%
12.12.21

Could be worthwhile Investment >10% per year
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€39.25
30.11.21
-
30.11.22
-17.83%
12.12.21

Probably not worthwhile Investment
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€17.00
28.11.21
-
28.11.22
7.65%
11.12.21

Could be worthwhile Investment >10% per year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.96
01.12.21
€6.00
01.12.22
-2.70%
11.12.21

Could be worthwhile Investment >10% per year
Innovative
Good culture
Below average Management
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.00
05.10.21
-
05.10.22
-10.00%
08.12.21

Probably not worthwhile Investment